Literature DB >> 20190882

Severe skin rash associated with atazanavir.

Andrew Walkty1, Dick Smith, Bernie Lopko, Ken Kasper.   

Abstract

Three cases of severe rash associated with the use of atazanavir are described. In all cases, the rash was maculopapular and pruritic. Rash onset occurred eight to 11 days after initiation of therapy, and resolved with atazanavir discontinuation. Clinicians prescribing atazanavir should be aware of this potential adverse effect.

Entities:  

Keywords:  Atazanavir; Rash

Year:  2009        PMID： 20190882      PMCID： PMC2690525          DOI： 10.1155/2009/721956

Source DB:  PubMed          Journal:  Can J Infect Dis Med Microbiol        ISSN： 1712-9532            Impact factor:   2.471


  12 in total

1.  Utility of patch testing in patients with hypersensitivity syndromes associated with abacavir.

Authors:  Elizabeth J Phillips; John R Sullivan; Sandra R Knowles; Neil H Shear
Journal:  AIDS       Date:  2002-11-08       Impact factor: 4.177

2.  Rash in an HIV-positive patient.

Authors:  C Herzmann; S Kinloch; M Johnson
Journal:  HIV Med       Date:  2005-11       Impact factor: 3.180

3.  Skin rash associated with atazanavir: report of three cases.

Authors:  Zineb Ouagari; Roland Tubiana; Hocine Ait Mohand; Stephanie Dominguez; Claudine Duvivier; François Bricaire; Christine Katlama; Eric Caumes
Journal:  AIDS       Date:  2006-05-12       Impact factor: 4.177

4.  Atazanavir plus ritonavir or saquinavir, and lopinavir/ritonavir in patients experiencing multiple virological failures.

Authors:  Margaret Johnson; Beatriz Grinsztejn; Claudia Rodriguez; Jeffrey Coco; Edwin DeJesus; Adriano Lazzarin; Kenneth Lichtenstein; Anna Rightmire; Serap Sankoh; Richard Wilber
Journal:  AIDS       Date:  2005-04-29       Impact factor: 4.177

5.  Efficacy and safety of atazanavir-based highly active antiretroviral therapy in patients with virologic suppression switched from a stable, boosted or unboosted protease inhibitor treatment regimen: the SWAN Study (AI424-097) 48-week results.

Authors:  Jose Gatell; Dominique Salmon-Ceron; Adriano Lazzarin; Eric Van Wijngaerden; Francisco Antunes; Clifford Leen; Andrzej Horban; Victoria Wirtz; Linda Odeshoo; Monique Van den Dungen; Claudia Gruber; Emilio Ledesma
Journal:  Clin Infect Dis       Date:  2007-04-25       Impact factor: 9.079

6.  Comparison of once-daily atazanavir with efavirenz, each in combination with fixed-dose zidovudine and lamivudine, as initial therapy for patients infected with HIV.

Authors:  Kathleen Squires; Adriano Lazzarin; José M Gatell; William G Powderly; Vadim Pokrovskiy; Jean-François Delfraissy; Joseph Jemsek; Antonio Rivero; Willy Rozenbaum; Shannon Schrader; Michael Sension; Asda Vibhagool; Alexandra Thiry; Michael Giordano
Journal:  J Acquir Immune Defic Syndr       Date:  2004-08-15       Impact factor: 3.731

7.  Antiretroviral treatment of adult HIV infection: 2008 recommendations of the International AIDS Society-USA panel.

Authors:  Scott M Hammer; Joseph J Eron; Peter Reiss; Robert T Schooley; Melanie A Thompson; Sharon Walmsley; Pedro Cahn; Margaret A Fischl; Jose M Gatell; Martin S Hirsch; Donna M Jacobsen; Julio S G Montaner; Douglas D Richman; Patrick G Yeni; Paul A Volberding
Journal:  JAMA       Date:  2008-08-06       Impact factor: 56.272

8.  Efficacy and safety of atazanavir, with or without ritonavir, as part of once-daily highly active antiretroviral therapy regimens in antiretroviral-naive patients.

Authors:  D R Malan; Edrich Krantz; Neal David; Victoria Wirtz; Janet Hammond; Donnie McGrath
Journal:  J Acquir Immune Defic Syndr       Date:  2008-02-01       Impact factor: 3.731

Review 9.  Severe cutaneous reactions associated with the use of human immunodeficiency virus medications.

Authors:  Adam Rotunda; Ranella J Hirsch; Noah Scheinfeld; Jeffrey M Weinberg
Journal:  Acta Derm Venereol       Date:  2003       Impact factor: 4.437

10.  HLA-B*5701 screening for hypersensitivity to abacavir.

Authors:  Simon Mallal; Elizabeth Phillips; Giampiero Carosi; Jean-Michel Molina; Cassy Workman; Janez Tomazic; Eva Jägel-Guedes; Sorin Rugina; Oleg Kozyrev; Juan Flores Cid; Phillip Hay; David Nolan; Sara Hughes; Arlene Hughes; Susanna Ryan; Nicholas Fitch; Daren Thorborn; Alastair Benbow
Journal:  N Engl J Med       Date:  2008-02-07       Impact factor: 91.245
View more
  1 in total

1.  Hypersensitivity Reaction Associated with Abacavir Therapy in an Indian HIV Patient - A Case Report.

Authors:  Manju Janardhanan; Mohan Babu Amberkar V; Sudha Vidyasagar; Meena Kumari K; Sadhana N Holla
Journal:  J Clin Diagn Res       Date:  2014-09-20
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.